Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 99mTc-methyl diphosphonate
Total 0 results
Nothing found
Sponsors and Collaborators
AlpinARC
Sublimity Therapeutics Holdco Limited
Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
The Australia-Israel Scientific Exchange Foundation (AISEF)
ECMC
the people hospital of Linzhi
Hospitales Universitarios Virgen del Rocío
National Institute of Cardiovascular Diseases, Bangladesh
Dr Philippe METELLUS
ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
Etan Orgel
Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
Glasgow Western Infirmary
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Åke Wibergs Stiftelse
Bassam Abdulkarim
Centro Universitário Franciscano
Daniela Pacella - University of Naples Federico II, Naples
Sahachat Aueyingsak
IRCCS Istituto Auxologico Italiano, Milano, Italy
View Full List
Medical Conditions
Degenerative Spondylolisthesis G1
Interviews
Ability to Swim 100m Independent Freestyle
Bladder Cancer TNM Staging Primary Tumor (T) T2B
Very Long Chain Acyl Coa Dehydrogenase Deficiency
Hyperprolinemia
Adult Patients Undergoing Surgery That Requires General Anesthesia
Legal History
Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
Pancreaticoduodenectomy
Initiation of Depo-Provera (DMPA)
Panniculectomy
Orthopaedic Disorders
Patients With Leptomeningeal Disease
Value-Based Health Insurance
Progression to PD-1 Antibody
Eosinophil Blood Count
Genetic Risk Factor
Transitional Cell Carcinoma of Renal Pelvis
Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
View Full List
Drug Interventions
Gefitinib
6% hetastarch
ASP8062
Prasugrel
Erythropoietin
Antibiotic treatment
ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
5-Fluoro-uracil
Metoclopramide + dexamethasone
Epirubicin hydrochloride
Paliperidone palmitate
Omeprazole 20mg
Mepivacaine
UFUR and Iressa
HBM4003 and Triprilimab
Nimotuzumab
IV rtPA (intravenous recombinant plasminogen activator)
Injectable Insulin
Cefuroxime 750mg oral
0% N2O
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Canada
Contract Research Organizations in Cyprus
Contract Research Organizations in Ecuador
Contract Research Organizations in Estonia
Contract Research Organizations in Malawi
Contract Research Organizations in Malaysia
Contract Research Organizations in Moldova
Contract Research Organizations in Oman
Contract Research Organizations in Qatar
Contract Research Organizations in Romania
Contract Research Organizations in Tanzania
Contract Research Organizations in Türkiye
CRO list by country
CROs in Morocco
SGS
4Clinics
MCT
"Gaya Pharma" by Morocco Africa Health & Pharma (MAHP)
All CROs in Morocco
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe